Ovarian Cancer

Ovarian Cancer Detection and Pathogenesis. - Potential and Limitations in Early Diagnosis of Ovarian Cancer. - SMRP and HE4 as Biomarkers for Ovarian Carcinoma When Used Alone and in Combination with CA125 and/or Each Other. - Classification of Ovarian Cancer: A Genomic Analysis. - Epigenetic Markers of Ovarian Cancer. - Role of Genetic Polymorphisms in Ovarian Cancer Susceptibility: Development of an International Ovarian Cancer Association Consortium. - MicroRNA in Human Cancer: One Step Forward in Diagnosis and Treatment. - Ovarian Carcinogenesis: An Alternative Hypothesis. - BRCA1-Induced Ovarian Oncogenesis. - Role of p53 and Rb in Ovarian Cancer. - Ovulatory Factor in Ovarian Carcinogenesis. - Ovarian Cancer Therapeutics. - Gynecologic Oncology Group (GOG-USA) Trials in Ovarian Cancer. - Intraperitoneal Chemotherapy for Ovarian Cancer. - Ovarian Cancer: Can We Reverse Drug Resistance? . - Syngeneic Mouse Model of Epithelial Ovarian Cancer: Effects of Nanoparticulate Paclitaxel, Nanotax®. - Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting the PI3K Pathway for Specific Patients. - Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer. - Nanoparticle Delivery of Suicide DNA for Epithelial Ovarian Cancer Therapy. - Biological Therapy with Oncolytic Herpesvirus. - Cancer Immunotherapy: Perspectives and Prospects. - Regulatory T Cells: A New Frontier in Cancer Immunotherapy. - Inhibitory B7 Family Members in Human Ovarian Carcinoma. - Role of Vascular Leukocytes in Ovarian Cancer Neovascularization. - Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a New Target Molecule for Cancer Therapy.